The U.S. Health Care System on the Eve of the Covid-19 Epidemic: A Summary of Recent Evidence on Its Impaired Performance.


Journal

International journal of health services : planning, administration, evaluation
ISSN: 1541-4469
Titre abrégé: Int J Health Serv
Pays: United States
ID NLM: 1305035

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 2 7 2020
medline: 4 9 2020
entrez: 2 7 2020
Statut: ppublish

Résumé

Four decades of neoliberal health policies have left the United States with a health care system that prioritizes the profits of large corporate actors, denies needed care to tens of millions, is extraordinarily fragmented and inefficient, and was ill prepared to address the COVID-19 pandemic. The payment system has long rewarded hospitals for providing elective surgical procedures to well-insured patients while penalizing those providing the most essential and urgent services, causing hospital revenues to plummet as elective procedures were cancelled during the pandemic. Before the recession caused by the pandemic, tens of millions of Americans were unable to afford care, compromising their physical and financial health; deep-pocketed corporate interests were increasingly dominating the hospital industry and taking over physicians' practices; and insurers' profits hit record levels. Meanwhile, yawning class-based and racial inequities in care and health outcomes remain and have even widened. Recent data highlight the failure of policy strategies based on market models and the need to shift to a nonprofit social insurance model.

Identifiants

pubmed: 32605414
doi: 10.1177/0020731420937631
pmc: PMC7331107
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

408-414

Références

JAMA Psychiatry. 2017 Sep 1;74(9):932-939
pubmed: 28724129
Health Aff (Millwood). 2019 Dec;38(12):2095-2104
pubmed: 31794306
JAMA Intern Med. 2019 May 28;:
pubmed: 31135825
JAMA Intern Med. 2019 Aug 12;:
pubmed: 31403651
JAMA. 2019 Nov 26;322(20):1996-2016
pubmed: 31769830
Health Aff (Millwood). 2019 Sep;38(9):1496-1504
pubmed: 31479367
Natl Vital Stat Rep. 2020 Jan;69(2):1-18
pubmed: 32510319
JAMA. 2019 Oct 8;322(14):1371-1380
pubmed: 31593271
Health Aff (Millwood). 2019 Nov;38(11):1801-1806
pubmed: 31682505
JAMA. 2019 Sep 10;322(10):957-973
pubmed: 31503308
JAMA. 2020 Feb 11;323(6):538-547
pubmed: 32044941
JAMA Intern Med. 2019 Oct 7;:
pubmed: 31589276
Health Aff (Millwood). 2020 Apr;39(4):704-714
pubmed: 32207998
N Engl J Med. 2020 Jan 9;382(2):152-162
pubmed: 31914242
Health Serv Res. 2020 Apr;55(2):224-231
pubmed: 31984503
Ann Intern Med. 2020 Feb 4;172(3):169-174
pubmed: 31931523
N Engl J Med. 2020 Jan 2;382(1):51-59
pubmed: 31893515
Health Aff (Millwood). 2020 Jan;39(1):33-40
pubmed: 31905070
JAMA Netw Open. 2020 Apr 1;3(4):e201451
pubmed: 32250432

Auteurs

David U Himmelstein (DU)

City University of New York at Hunter College, New York, USA.

Steffie Woolhandler (S)

Harvard Medical School, Cambridge, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH